4G Clinical secures investment from Goldman Sachs
Goldman Sachs Asset Management has invested over $230 million in 4G Clinical, a randomization and trial supply management company.
29 June 2021•3 mins read
Goldman Sachs Asset Management has invested over $230 million in 4G Clinical, a randomization and trial supply management company.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
18 hours ago · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
18 hours ago · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
19 hours ago · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
19 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
19 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
19 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
21 hours ago · 3 mins read
